Horizon Pharma

About:

Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.

Website: https://www.horizontherapeutics.com

Twitter/X: HorizonNews

Top Investors: Deerfield, Sutter Hill Ventures, Silicon Valley Bank, Scale Venture Partners, Citigroup Global Markets

Description:

Horizon Therapeutics operates as a biopharmaceutical company. It focuses on the development of prescription drugs for mild to moderate pain relief and arthritis. The company's product candidates include HZT-501, a proprietary fixed-dose combination formulation of NSAID and ibuprofen; and HZT-602, a combination oral drug product consisting of naproxen and famotidine. Horizon Therapeutics is based in Northbrook, Illinois, and was founded in 2005.